Whole-brain Radiotherapy with and Without Concurrent Erlotinib in NSCLC with Brain Metastases: a Multicenter, Open-Label, Randomized, Controlled Phase III Trial
NEURO-ONCOLOGY（2021）
Key words
brain metastases,epidermal growth factor receptor,erlotinib,non-small cell lung cancer,whole-brain radiation therapy
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined